33972
3,5,6-Trichloro-2-pyridinol
PESTANAL®, analytical standard
Synonym(s):
2,3,5-Trichloro-6-hydroxypyridine, 3,5,6-Trichloro-2-pyridone, TCP
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Empirical Formula (Hill Notation):
C5H2Cl3NO
CAS Number:
Molecular Weight:
198.43
NACRES:
NA.24
PubChem Substance ID:
UNSPSC Code:
41116107
EC Number:
229-405-2
MDL number:
grade
analytical standard
Quality Level
product line
PESTANAL®
shelf life
limited shelf life, expiry date on the label
technique(s)
HPLC: suitable, gas chromatography (GC): suitable
application(s)
agriculture
environmental
format
neat
SMILES string
Oc1nc(Cl)c(Cl)cc1Cl
InChI
1S/C5H2Cl3NO/c6-2-1-3(7)5(10)9-4(2)8/h1H,(H,9,10)
InChI key
WCYYAQFQZQEUEN-UHFFFAOYSA-N
General description
3,5,6-Trichloro-2-pyridinol (TCP) is an organophosphorous insecticide, which can be obtained as a major degradation product of chlorpyrifos (CP), via treatment with the degrading bacteria Enterobacter B-14.
Application
Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.
Legal Information
PESTANAL is a registered trademark of Merck KGaA, Darmstadt, Germany
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1
Storage Class
11 - Combustible Solids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Jan Rozman et al.
Nature communications, 9(1), 288-288 (2018-01-20)
Metabolic diseases are a worldwide problem but the underlying genetic factors and their relevance to metabolic disease remain incompletely understood. Genome-wide research is needed to characterize so-far unannotated mammalian metabolic genes. Here, we generate and analyze metabolic phenotypic data of
Tse-Hsiang Chen et al.
Tissue engineering. Part A, 24(19-20), 1554-1561 (2018-07-13)
Additive manufacturing of bone tissue engineering scaffolds will become a key element for personalized bone tissue engineering in the near future. Several additive manufacturing processes are based on extrusion where the deposition of the filament will result in a three-dimensional
Wanqiu Zhu et al.
Medicine, 95(46), e5202-e5202 (2016-11-20)
Renal insufficiency is a common and severe complication of patients with multiple myeloma. The aim of this study was to evaluate bortezomib-based treatment for multiple myeloma patients with renal insufficiency. The Cochrane Library, Embase, PubMed, ISI, China National Knowledge Infrastructure